TScan Therapeutics, Inc.
TCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001783328
No open-market purchases or sales by TScan Therapeutics, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $35.1M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in TScan Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +3 vs. Q3 2021
- Shares held
- 9.86M
- +972.5K (+10.9%) vs. Q3 2021
- Total value
- $44.4M
- −$29.8M (−40.1%) vs. Q3 2021
- New holders
- 10
- 2 more added
- Sold out
- 7
- 6 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $35.1M |
| Q1 2026 | 60 | $32.8M |
| Q4 2025 | 61 | $30.7M |
| Q3 2025 | 73 | $62.9M |
| Q2 2025 | 81 | $51.8M |
| Q1 2025 | 92 | $55.4M |
| Q4 2024 | 89 | $126.2M |
| Q3 2024 | 89 | $208.3M |
| Q2 2024 | 81 | $242.6M |
| Q1 2024 | 66 | $272.3M |
| Q4 2023 | 54 | $186.1M |
| Q3 2023 | 32 | $73.2M |
| Q2 2023 | 28 | $69.9M |
| Q1 2023 | 28 | $20.3M |
| Q4 2022 | 28 | $14.8M |
| Q3 2022 | 26 | $29.0M |
| Q2 2022 | 24 | $30.4M |
| Q1 2022 | 25 | $26.3M |
| Q4 2021 | 29 | $44.4M |
| Q3 2021 | 27 | $83.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding TScan Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 41 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 189 | $1.00K | 0.00% | +189 | New |
| UBS Group AG | 811 | $4.00K | 0.00% | −135−14.3% | Reduced |
| Royal Bank of Canada | 1,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,770 | $17.0K | 0.00% | +3,770 | New |
| Jane Street Group, LLC | 11,307 | $51.0K | 0.00% | +11,307 | New |
| Millennium Management LLC | 12,276 | $55.0K | 0.00% | −17,964−59.4% | Reduced |
| State Street Corp | 12,200 | $55.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 13,000 | $59.0K | 0.00% | +13,000 | New |
| HRT Financial LP | 20,829 | $93.0K | 0.00% | +20,829 | New |
| Marquette Asset Management, LLC | 21,618 | $97.0K | 0.02% | +21,618 | New |
| Geode Capital Management, LLC | 25,421 | $114.0K | 0.00% | +12,635+98.8% | Added |
| Caas Capital Management LP | 25,633 | $115.0K | 0.01% | −49,367−65.8% | Reduced |
| Morgan Stanley | 27,404 | $123.0K | 0.00% | −832−2.9% | Reduced |
| DC Investments Management, LLC | 35,563 | $160.0K | 0.23% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 40,000 | $180.0K | 0.00% | +40,000 | New |
| Nan Fung Group Holdings Ltd | 48,600 | $219.0K | 0.06% | +48,600 | New |
| Norges Bank | 60,000 | $270.0K | 0.00% | 00.0% | Unchanged |
| Woodline Partners LP | 99,900 | $450.0K | 0.01% | +99,900 | New |
| Tekla Capital Management LLC | 200,000 | $900.0K | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 238,014 | $1.07M | 0.00% | −206,880−46.5% | Reduced |
| Adage Capital Partners GP, L.L.C. | 550,000 | $2.48M | 0.00% | +53,417+10.8% | Added |
| DC Funds, LP | 630,000 | $2.83M | 16.79% | 00.0% | Unchanged |
| Alphabet Inc. | 1,077,080 | $4.85M | 0.12% | 00.0% | Unchanged |
| Deer Management Co. LLC | 1,245,505 | $5.61M | 0.14% | +1,245,505 | New |
| Ra Capital Management, L.P. | 1,255,317 | $5.65M | 0.10% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 1,282,976 | $5.77M | 0.09% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 1,425,000 | $6.41M | 0.03% | 00.0% | Unchanged |
| BlackRock Inc. | 1,498,538 | $6.74M | 0.00% | −2,039−0.1% | Reduced |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −139,566−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −22,817−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −22,200−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −11,922−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −11,531−100.0% | Sold out |
| Deer IX & Co. Ltd. | – | – | – | – | Not filed |